Literature DB >> 28244743

The Ecstasy and Agony of Assay Interference Compounds.

Courtney Aldrich1, Carolyn Bertozzi2, Gunda I Georg3, Laura Kiessling4, Craig Lindsley5, Dennis Liotta6, Kenneth M Merz7, Alanna Schepartz8, Shaomeng Wang3.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 28244743     DOI： 10.1021/acs.jcim.7b00105

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN： 1549-9596            Impact factor:   4.956


× No keyword cloud information.
  4 in total

1.  Computer-Aided Discovery and Characterization of Novel Ebola Virus Inhibitors.

Authors:  Stephen J Capuzzi; Wei Sun; Eugene N Muratov; Carles Martínez-Romero; Shihua He; Wenjun Zhu; Hao Li; Gregory Tawa; Ethan G Fisher; Miao Xu; Paul Shinn; Xiangguo Qiu; Adolfo García-Sastre; Wei Zheng; Alexander Tropsha
Journal:  J Med Chem       Date:  2018-04-17       Impact factor: 7.446

2.  X-ray-Structure-Based Identification of Compounds with Activity against Targets from Different Families and Generation of Templates for Multitarget Ligand Design.

Authors:  Erik Gilberg; Dagmar Stumpfe; Jürgen Bajorath
Journal:  ACS Omega       Date:  2018-01-05

3.  Quantitative high-throughput screening assays for the discovery and development of SIRPα-CD47 interaction inhibitors.

Authors:  Thomas W Miller; Joshua D Amason; Elsa D Garcin; Laurence Lamy; Patricia K Dranchak; Ryan Macarthur; John Braisted; Jeffrey S Rubin; Teresa L Burgess; Catherine L Farrell; David D Roberts; James Inglese
Journal:  PLoS One       Date:  2019-07-05       Impact factor: 3.240

4.  Identifying Promiscuous Compounds with Activity against Different Target Classes.

Authors:  Christian Feldmann; Filip Miljković; Dimitar Yonchev; Jürgen Bajorath
Journal:  Molecules       Date:  2019-11-18       Impact factor: 4.411
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.